Citation: Guizhen Zhu, Yaoyao Zhao, Wenmei Zhang, Yuanyuan Wu, Yuanxing Liu, Guangsheng Guo, Xiayan Wang, Zhihong Liu. Single-cell mass spectrometry studies of drug metabolism heterogeneity and primary resistance to gefitinib in non-small cell lung cancer cells[J]. Chinese Chemical Letters, ;2024, 35(2): 108466. doi: 10.1016/j.cclet.2023.108466 shu

Single-cell mass spectrometry studies of drug metabolism heterogeneity and primary resistance to gefitinib in non-small cell lung cancer cells

    * Corresponding authors.
    E-mail addresses: zhaoyaoyao@bjut.edu.cn (Y. Zhao), zhhliu@whu.edu.cn (Z. Liu).
  • Received Date: 9 March 2023
    Revised Date: 23 March 2023
    Accepted Date: 16 April 2023
    Available Online: 21 April 2023

Figures(6)

  • Patients with epidermal growth factor receptor (EGFR) wild-type non-small cell lung cancer (NSCLC) often show primary resistance to gefitinib therapy. It is thus necessary to study the metabolism of gefitinib in NSCLC cells to comprehensively reveal the reasons for the primary resistance of tumors. Herein, we develop a platform for studying drug metabolism heterogeneity based on single-cell mass spectrometry (sDMH-scMS) by integrating living-cell electrolaunching ionization MS (ILCEI-MS) and high-performance liquid chromatography-MS (HPLC-MS) analysis, and the primary resistance of NSCLC cells to gefitinib was studied using this platform. The ILCEI-MS analysis showed that approximately 11.9% of NSCLC single cells contained the gefitinib metabolite M11; HPLC-MS detection diluted the intensity of M11 in subpopulations and concealed the heterogeneity of drug metabolism in tumor single cells. The intensity of gefitinib in EGFR wild-type A549 cells was markedly lower than in mutant PC9 cells, and the intensity of gefitinib metabolites was significantly higher than in PC9 cells, suggesting that the primary resistance of NSCLC cells is related to gefitinib metabolism. Moreover, the combination of gefitinib and the drug-metabolizing enzyme inhibitor α-naphthoflavone was shown to overcome the primary resistance of the NSCLC cells. Overall, the results of this study are expected to be applicable for clinical drug resistance diagnosis and treatment at the single-cell level.
  • Lanthanide complexes are crystalline hybrid materials assembled by trivalent lanthanide (Ln3+) ions and organic ligands [1-3]. Benefiting from the antenna effect, characteristic luminescence of Ln3+ ions, especially Eu3+ and Tb3+ ions, are well sensitized by the light-harvesting ligands via a series of energy transfer processes [4-6]. These complicated photoluminescence pathways determine the sensitive nature to circumstance details, thereby providing an effective platform for chemically responding to metal cations, oxoanions, organic solvents, and biomolecules [7-10]. However, it is commonly believed that luminescent lanthanide complexes are unsuitable for water-bearing systems, because the stretching vibration of hydroxyl groups in water molecules confines the energy transfer process from the triplet state of ligand to the receiving energy level of Ln3+ ions, leading to dramatic luminescence quenching [11-13]. This greatly limits the practicality of lanthanide-based luminescence complexes. Therefore, it is meaningful, though challengeable, to develop a water-stable even water-improving luminescence lanthanide complex.

    Enhancing hydrophobicity of luminophores and thereafter inhibiting the immediate contact with solvent water molecules is a potential mean to settle the above-mentioned water-induced luminescence quenching issue [14]. Based on this consideration, (HNEt3)+[Eu(DBM)4] (briefly as Eu-DBM, DBM = dibenzoylmethane) is selected as a luminophore (Figs. S1 and S2 in Supporting information) [15]. Firstly, its phenyl-surrounding outside surface provides strong hydrophobicity. Secondly, it has coordination-saturated lanthanide centre, which could decrease the impact of coordination solvent molecular replacement and further weaken the water-induced effect to lanthanide luminescence. Thirdly, its anionic framework is helpful to the dispersibility in polar solvents such as water. Therefore, in this work, the Eu-DBM material is selected as a luminophore to study its potential on water-induced luminescence improvement. For further enhancing the dispersibility and stability, the nanosheet-like Eu-DBM material is also prepared. Then, its application on sensitive detection toward extended organic solvents in water has been investigated.

    A top-down strategy was utilized to prepare the Eu-DBM nanosheet by two facile steps. The bulky crystal of Eu-DBM was firstly prepared in terms of a previous method [15]. It was then exfoliated into nanosheets under 720 W ultrasonication for 24 h at room temperature. Atomic force microscopy (AFM) image revealed its two-dimensional (2D) sheet-like morphology with a height of uniform 12 nm (Fig. 1a). Scanning electron microscopy (SEM) image further confirmed a sheet-like appearance with the size of 100–200 nm (Fig. 1b). Fourier transition infrared (FT-IR), ultraviolet-visible absorption (UV-vis) thermogravimetric differential thermal analysis (TG-DTA) spectra, and the powder X-ray diffraction pattern of the Eu-DBM nanosheet held similar patterns with those of bulky ones reported previously (Figs. S3–S6 in Supporting information) [15]. Furthermore, elemental mapping analysis further proved the composition consisted of C, O and Eu elements (Fig. 1c). Elementary analysis, X-ray photoelectron spectroscopy (XPS), and energy disperse spectroscopy (EDS) presented an agreeable proportion of elements with crystallographic data (Table S1 in Supporting information) [15]. These results indicated that the obtained Eu-DBM nanosheets had the same structure and composition as their bulky crystals.

    Figure 1

    Figure 1.  AFM (a), SEM (b), and elemental mapping (c) images of Eu-DBM nanosheets. 3D photoluminescent spectra of Eu-DBM nanosheet in solid state (d) and in aqueous solution (e). (f) Comparison of lifetime and quantum yield in this work with previous reports. (g) Comparison of Eu-DBM bulky crystal and nanosheet in solid state and in aqueous suspension.

    The three-dimensional (3D) photoluminescence (PL) spectra of Eu-DBM nanosheet exhibited strong emission at 614 nm throughout the excitation from 250 nm to 390 nm, rendering stable and intense red-light emission with the Commission Internationale de L'Eclairage (CIE) coordination of (0.648, 0.330) (Fig. 1d and Fig. S7 in Supporting information). This excitation-wavelength independence in such a broad range was rarely reported in the luminescence lanthanide complexes [12, 13]. The unsplit band at 614 nm implied a highly symmetric structure of the Eu-DBM complex [16]. The electric dipole transition (5D07F2) at 614 nm was approximately 22-fold stronger than the magnetic one (5D07F1) at 592 nm, indicating the highly symmetric coordination environment of central Eu3+ ion in the complex [17]. Noteworthily, after dispersing the Eu-DBM nanosheet in water, the 1 g/L suspension presented the nearly same 3D PL contour as the solid-state one, exhibiting the strong red-light emission (Fig. 1e). The time-dependent curve showed that the luminescent intensity at 614 nm could remain at least 24 h with a < 5% declination (Fig. S8 in Supporting information). This excellent stability originated from the good dispersibility of the complex nanosheets in water.

    The presence of strong Eu3+ characteristic luminescence and the absence of DBM ligand fluorescence suggested an effective antenna effect in the Eu-DBM complex: the adsorbed UV light by DBM ligand could effectively transfer to the Eu3+ ion, and then sensitize its characteristic luminescence. To confirm this hypothesis, the sensitization efficiency (ηET) was subsequently calculated in terms of the following equations Eqs. 1–3 [18-20].

    (1)

    (2)

    (3)

    According to Eq. 1, Φoverall was the overall luminescence quantum yield measured by the integrated sphere method (Table S2 in Supporting information). ΦLn was the intrinsic quantum yield of the lanthanide luminescence, obtained in terms of Eq. 2, where the observed lifetime (τobs) was determined by monitoring the emission decaying curve within the 5D07F2 transition at 614 nm (Figs. S9–S11 in Supporting information). The calculated radiative lifetime (τrad) could be calculated through Eq. 3, where AMD, 0 was the spontaneous emission probability of the magnetic dipole transition and equated to 14.65 s−1 for Eu3+ ion (5D07F1); n represented the refractive index of the tested sample (n equated to 1.55 for solid-state Eu-DBM and 1.33 for Eu-DBM nanosheets aqueous suspension); Itot and IMD were the integrated emission of the total 5D07FJ transition and the 5D07F1 transition, respectively. As a result, the Eu-DBM bulky crystal and nanosheet in solid state and in aqueous suspension exhibited high τobs and Φoverall values, surpassing most of the reported luminescent lanthanide complexes and nearly all the Eu-DBM-based complexes (Fig. 1f). Compared with the solid-state Eu-DBM, the 1 g/L aqueous suspension of Eu-DBM nanosheets showed only slight declination on τobs and Φoverall (Table S2 and Figs. S9–S11). Noteworthily, the ηET in Eu-DBM aqueous suspension was calculated as 46.7%, a 13.0% and 13.3% improvement compared with that of the bulky crystal and solid-state nanosheets (Fig. 1g). This improvement on sensitization efficiency states the increasing energy transfer from the DBM ligand to the central Eu3+ ions. In other words, the water solvent improved the luminescence of Eu3+ ion, realizing the water-induced luminescence improvement which is rarely reported previously (Table S2).

    The mechanism of this water-induced luminescence improvement in the Eu-DBM complex was then explored. Firstly, the Eu-DBM was dispersed in various common solvents to prepare 1 g/L solution or suspension. As seen in Fig. 2a, the complex exhibited poor solubility in water but good in nearly all other common organic solvents. This derived from the strong hydrophobic property due to the phenyl-surrounding outside surface of Eu-DBM. Comparatively, the aqueous suspension of the Eu-DBM nanosheets presented strong and uniform red-light-emission of characteristic Eu3+ ion (Figs. 2b and c). However, the Eu-DBM solution in various common organic solvents was obviously quenched. These excellent and unorthodox photophysical properties of Eu-DBM in water system could attribute to the insolubility and aggregation state which avoided the immediate contact between water molecules and the central Eu3+ ions. Secondly, given that water possesses the highest surface tension and polarity among all solvents, it could suppress surficial phenyl groups and yield structural modification. According to Fig. S5, the PXRD pattern of the Eu-DBM nanosheet had strong peak at 7.0o, which indicated that the (200) plane was exposed to water solvent, as shown in Fig. 2d. The strong surface tension of solvent water molecules could compress the hydrophobic phenyl groups inward, resulting in the more planarity between the neighboring phenyl and carbonyl groups. This enhanced the π-π conjugation and suppressed the stretching vibration of the C–C bond of benzene rings. After the benzene rings are fixed, the energy loss caused by the vibration of the chemical bonds were reduced, making the more effective sensitization of Eu3+ ions (Fig. 2d). Moreover, the dihedral angle and distances between neighboring phenyl/carboxyl planes was decreasing after putting Eu-DBM nanosheets into water environment, which promoted the through-space charge transfer (TSCT) process [21-23]. To prove this hypothesis, the Eu-DBM molecule in the water environment was geometrically optimized by theoretical calculation by using Material Studio 8.0 software with GGA/BLYP basis set [24]. As shown in Fig. 3, under the effect of the water molecule, a more planarity between phenyl and carbonyl groups could be observed. The dihedral angle between the neighboring phenyl/carbonyl planes were also reduced by 11.6° and 7.3°, respectively, compared with the original structure. This confirmed that the water-induced luminescence improvement primarily resulted from the TSCT process as discussed above.

    Figure 2

    Figure 2.  Photo images of Eu-DBM samples in various solvents under daylight (a) and UV lamp (b). Photoluminescent spectra of Eu-DBM samples in various solvents upon the excitation of 304 nm (c). Mechanism of water-induced luminescence improvement (d).

    Figure 3

    Figure 3.  Geometrically optimized structure of Eu-DBM without water (left) and with water (right). H and (HNEt3)+ have been transparentized.

    Considering that the as-prepared Eu-DBM nanosheet presented excellent luminescence improvement in water and obvious quenching in other organic solvents, it could act as a luminescence sensor toward extensive organic solvents in water, being an indicator to monitor water purity. Based on this, various organic solvents were gradually titrated into 1 g/L Eu-DBM aqueous suspension. By monitoring their luminescence intensity at 614 nm upon the 304 nm excitation, the relationship between volume proportion (v/v) and quenching efficiency was depicted in Figs. 4a and b. The luminescence intensity dramatically decreased upon the addition of various organic solvents. When the volume proportion of added organic solvent was approximate 2.5%, the luminescence intensity dropped by about 50%. In other words, the nanosheets exhibited similar and sensitive changes in luminescence intensity toward nearly all organic solvents. To the best of our knowledge, this colligative property toward such extensive sensibility was rarely reported and applicable for water purity monitor. As shown in Figs. 4cl, the Eu-DBM aqueous suspension turned to be more pellucid as the gradual addition of various organic solvents. The luminescent intensity observed by naked eyes also presented an obvious decrease under the 365 nm UV lamp.

    Figure 4

    Figure 4.  (a, b) Relationship between the relative luminescent intensity of Eu-DBM sensor and the added quantity of organic solvents. Photo images under daylight and UV lamp of Eu-DBM sensor upon adding DMSO (c), EG(d), THF (e), DMA (f), acetone (g), n-propanol (h), DMF (i), EtOH (j), acetonitrile (k) and MeOH (l).

    Then, we quantitatively examined the luminescent quenching coefficient (KSV) of the Eu-DBM sensor toward various organic solvents in water via the distinguished Stern-Volmer (SV) equation: I0/I – 1 = KSV × [C]n, where I0 and I were the luminescent intensity before and after adding analytes, and [C] was the molar concentration of the analyte [25, 26]. The parameter n equalled to 1 when the SV curve displayed a linear relationship. According to Figs. S12–S31(Supporting information), the SV curve of the Eu-DBM sensor displayed a linear relationship in the concentration range of 0–0.6 mol/L toward DMA, DMF, DMSO, EtOH, MeOH, acetonitrile, and n-propanol, but a distinct curvature toward THF, acetone, and ethylene glycol (EG). The calculated KSV values were in order of acetone (8.85 L/mol) > THF (7.35 L/mol) > DMF (7.22 L/mol) > EtOH (6.54 L/mol) > n-propanol (4.79 L/mol) > acetonitrile (2.54 L/mol) > MeOH (2.52 L/mol) > DMA (2.78 L/mol) > DMSO (2.43 L/mol) > EG (2.11 L/mol). Subsequently, the limitations of detection (LODs) were calculated via the formula of 3σ/KSV, where σ is the standard deviation of the luminescent intensity for five-time blank measurement at 2 min intervals [27-30]. As a result, the LODs toward various organic solvents ranged from 4.07 × 10−4 mol/L to 1.43 × 10−3 mol/L. In order to improve the detection convenience, the relationship between the volume ratio of the 10 organic solvents and the relative luminescence intensity was averaged and the polynomial fitting was performed (Fig. S32 in Supporting information). The relationship between them is approximately fitted as y = 5.23x2 – 35.47x + 100.00 and R2 = 0.999. This extensive sensibility toward nearly all organic solvents in water demonstrated that the as-prepared Eu-DBM nanosheets could be utilized to ratiometrically determine the organic solvents in water. In addition, the sensor could be regenerated and reused for at least five cycles by centrifugation of the solution after use and washing several times with water (Figs. S33–S42 in Supporting information).

    In conclusion, the water-stable Eu-DBM nanosheets exhibited exceptional water-induced luminescence improvement phenomenon, with a 13% improvement for sensitization efficiency. This attributes to the combined effect of hydrophobic-caused aggregation and through-space charge transfer in the water environment. Moreover, the well-dispersed aqueous suspension of Eu-DBM nanosheets could act as a luminescence sensor which responses to trace organic solvents in water, with good universality and recyclability. In this work, the water-induced luminescence improvement and extensive sensibility toward organic solvents in water were rarely reported previously in lanthanide-based materials. The successful development of this material provided a new platform for luminescent sensors in the water system, being practical values on monitoring water quality.

    The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

    We thank the National Natural Science Foundation of China (No. 22075071), and Reform and Development Fund Project of Local University supported by the Central Government.

    Supplementary material associated with this article can be found, in the online version, at doi: 10.1016/j.cclet.2021.08.080.


    1. [1]

      I. Solassol, F. Pinguet, X. Quantin, Biomolecules 9 (2019) 668.  doi: 10.3390/biom9110668

    2. [2]

      J.G. Paez, P.A. Janne, J.C. Lee, et al., Science 304 (2004) 1497–1500.  doi: 10.1126/science.1099314

    3. [3]

      H. -. R. Kim, J.C. Lee, Y. -. C. Kim, et al., Lung Cancer 83 (2014) 252–258.  doi: 10.1016/j.lungcan.2013.11.008

    4. [4]

      E.N. Imyanitov, A.G. Iyevleva, E.V. Levchenko, Crit. Rev. Oncol. Hematol. 157 (2021) 103194.  doi: 10.1016/j.critrevonc.2020.103194

    5. [5]

      J.H. Baek, J.M. Sun, Y.J. Min, et al., Lung Cancer 87 (2015) 148–154.  doi: 10.1016/j.lungcan.2014.11.013

    6. [6]

      E. Tsvetkova, G.D. Goss, Curr. Oncol. 19 (2012) S45–S51.  doi: 10.3747/co.19.1113

    7. [7]

      H. Linardou, I.J. Dahabreh, D. Bafaloukos, et al., Nat. Rev. Clin. Oncol. 6 (2009) 352–366.  doi: 10.1038/nrclinonc.2009.62

    8. [8]

      P.I. Poulikakos, C. Zhang, G. Bollag, et al., Nature 464 (2010) 427–430.  doi: 10.1038/nature08902

    9. [9]

      C. Yamamoto, Y. Basaki, A. Kawahara, et al., Cancer Res. 70 (2010) 8715–8725.  doi: 10.1158/0008-5472.CAN-10-0043

    10. [10]

      R.R. Alfieri, M. Galetti, S. Tramonti, et al., Mol. Cancer 10 (2011) 143.  doi: 10.1186/1476-4598-10-143

    11. [11]

      L. Huang, L. Fu, Acta Pharm. Sin. B 5 (2015) 390–401.  doi: 10.1016/j.apsb.2015.07.001

    12. [12]

      C. Hegedus, K. Truta-Feles, G. Antalffy, et al., Biochem. Pharmacol. 84 (2012) 260–267.  doi: 10.1016/j.bcp.2012.04.010

    13. [13]

      J. Rawluk, C.F. Waller, Gefitinib, in: U. Martens (Ed.), Small Molecules in Oncology, Recent Results in Cancer Research, Springer, Cham, 2018, pp. 235–246.

    14. [14]

      C. Zhao, N. Zheng, F. Yang, et al., Biomed. Chromatogr. 33 (2019) e4638.  doi: 10.1002/bmc.4638

    15. [15]

      D. McKillop, A.D. McCormick, G.S. Miles, et al., Xenobiotica 34 (2004) 983–1000.  doi: 10.1080/02772240400015222

    16. [16]

      D. McKillop, A.D. McCormick, A. Millar, et al., Xenobiotica 35 (2005) 39–50.  doi: 10.1080/00498250400026464

    17. [17]

      X. Liu, Y. Lu, X. Guan, et al., Biochem. Pharmacol. 97 (2015) 111–121.

    18. [18]

      D. McKillop, M. Hutchison, E.A. Partridge, et al., Xenobiotica 34 (2004) 917–934.  doi: 10.1080/00498250400009171

    19. [19]

      C. Wang, J. Zhang, S. Zhou, et al., PLoS ONE 15 (2020) e0236523.  doi: 10.1371/journal.pone.0236523

    20. [20]

      J. Li, M. Zhao, P. He, et al., Clin. Cancer Res. 13 (2007) 3731–3737.  doi: 10.1158/1078-0432.CCR-07-0088

    21. [21]

      C. Zhao, S.Y. Han, P.P. Li, Curr. Drug Deliv. 14 (2017) 282–288.  doi: 10.3390/ma10030282

    22. [22]

      G. Zhu, Y. Shao, Y. Liu, et al., Trac-Trends Anal. Chem. 143 (2021) 116351.  doi: 10.1016/j.trac.2021.116351

    23. [23]

      L. Zhang, A. Vertes, Angew. Chem. Int. Ed. 57 (2018) 4466–4477.  doi: 10.1002/anie.201709719

    24. [24]

      Y. Liu, Y. Mi, T. Mueller, et al., Nat. Biotechnol. 37 (2019) 314–322.  doi: 10.1038/s41587-019-0037-y

    25. [25]

      U. Ben-David, B. Siranosian, G. Ha, et al., Nature 560 (2018) 325–330.  doi: 10.1038/s41586-018-0409-3

    26. [26]

      Y. Shen, B.U.S. Schmidt, H. Kubitschke, et al., Cancer Converg. 4 (2020) 1.  doi: 10.1186/s41236-020-0010-1

    27. [27]

      N. Pan, S.J. Standke, N.R. Kothapalli, et al., Anal. Chem. 91 (2019) 9018–9024.  doi: 10.1021/acs.analchem.9b01311

    28. [28]

      M. Sun, X. Chen, Z. Yang, Anal. Chim. Acta 1206 (2022) 339761.  doi: 10.1016/j.aca.2022.339761

    29. [29]

      Z. Shen, H. Zhao, H. Yao, et al., Chem. Sci. 13 (2022) 1641–1647.  doi: 10.1039/d1sc06366a

    30. [30]

      S. Xu, M. Liu, Y. Bai, et al., Angew. Chem. Int. Ed. 60 (2021) 1806–1812.  doi: 10.1002/anie.202009682

    31. [31]

      X. Chen, Z. Peng, Z. Yang, Chem. Sci. 13 (2022) 6687–6695.  doi: 10.1039/d2sc02298b

    32. [32]

      M. Zhuang, Z. Hou, P. Chen, et al., Chem. Sci. 11 (2020) 7308–7312.  doi: 10.1039/d0sc00259c

    33. [33]

      W. Zhang, N. Li, L. Lin, et al., Small 15 (2019) 1903402.

    34. [34]

      G. Zhu, W. Zhang, Y. Zhao, et al., Anal. Chem. 95 (2023) 4712–4720.  doi: 10.1021/acs.analchem.2c05351

    35. [35]

      C. Wang, W. Hu, L. Guan, et al., Chin. Chem. Lett. 33 (2022) 2883–2892.  doi: 10.1016/j.cclet.2021.10.006

    36. [36]

      Y. Shao, Y. Zhou, Y. Liu, et al., Chem. Sci. 13 (2022) 8065–8073.  doi: 10.1039/d2sc02569h

    37. [37]

      L. Wang, W. Peng, T. Wu, et al., Cell Death Discov. 4 (2018) 84.  doi: 10.1038/s41420-018-0086-x

    38. [38]

      X. Li, T.M. Kamenecka, M.D. Cameron, Chem. Res. Toxicol. 22 (2009) 1736–1742.  doi: 10.1021/tx900256y

    1. [1]

      I. Solassol, F. Pinguet, X. Quantin, Biomolecules 9 (2019) 668.  doi: 10.3390/biom9110668

    2. [2]

      J.G. Paez, P.A. Janne, J.C. Lee, et al., Science 304 (2004) 1497–1500.  doi: 10.1126/science.1099314

    3. [3]

      H. -. R. Kim, J.C. Lee, Y. -. C. Kim, et al., Lung Cancer 83 (2014) 252–258.  doi: 10.1016/j.lungcan.2013.11.008

    4. [4]

      E.N. Imyanitov, A.G. Iyevleva, E.V. Levchenko, Crit. Rev. Oncol. Hematol. 157 (2021) 103194.  doi: 10.1016/j.critrevonc.2020.103194

    5. [5]

      J.H. Baek, J.M. Sun, Y.J. Min, et al., Lung Cancer 87 (2015) 148–154.  doi: 10.1016/j.lungcan.2014.11.013

    6. [6]

      E. Tsvetkova, G.D. Goss, Curr. Oncol. 19 (2012) S45–S51.  doi: 10.3747/co.19.1113

    7. [7]

      H. Linardou, I.J. Dahabreh, D. Bafaloukos, et al., Nat. Rev. Clin. Oncol. 6 (2009) 352–366.  doi: 10.1038/nrclinonc.2009.62

    8. [8]

      P.I. Poulikakos, C. Zhang, G. Bollag, et al., Nature 464 (2010) 427–430.  doi: 10.1038/nature08902

    9. [9]

      C. Yamamoto, Y. Basaki, A. Kawahara, et al., Cancer Res. 70 (2010) 8715–8725.  doi: 10.1158/0008-5472.CAN-10-0043

    10. [10]

      R.R. Alfieri, M. Galetti, S. Tramonti, et al., Mol. Cancer 10 (2011) 143.  doi: 10.1186/1476-4598-10-143

    11. [11]

      L. Huang, L. Fu, Acta Pharm. Sin. B 5 (2015) 390–401.  doi: 10.1016/j.apsb.2015.07.001

    12. [12]

      C. Hegedus, K. Truta-Feles, G. Antalffy, et al., Biochem. Pharmacol. 84 (2012) 260–267.  doi: 10.1016/j.bcp.2012.04.010

    13. [13]

      J. Rawluk, C.F. Waller, Gefitinib, in: U. Martens (Ed.), Small Molecules in Oncology, Recent Results in Cancer Research, Springer, Cham, 2018, pp. 235–246.

    14. [14]

      C. Zhao, N. Zheng, F. Yang, et al., Biomed. Chromatogr. 33 (2019) e4638.  doi: 10.1002/bmc.4638

    15. [15]

      D. McKillop, A.D. McCormick, G.S. Miles, et al., Xenobiotica 34 (2004) 983–1000.  doi: 10.1080/02772240400015222

    16. [16]

      D. McKillop, A.D. McCormick, A. Millar, et al., Xenobiotica 35 (2005) 39–50.  doi: 10.1080/00498250400026464

    17. [17]

      X. Liu, Y. Lu, X. Guan, et al., Biochem. Pharmacol. 97 (2015) 111–121.

    18. [18]

      D. McKillop, M. Hutchison, E.A. Partridge, et al., Xenobiotica 34 (2004) 917–934.  doi: 10.1080/00498250400009171

    19. [19]

      C. Wang, J. Zhang, S. Zhou, et al., PLoS ONE 15 (2020) e0236523.  doi: 10.1371/journal.pone.0236523

    20. [20]

      J. Li, M. Zhao, P. He, et al., Clin. Cancer Res. 13 (2007) 3731–3737.  doi: 10.1158/1078-0432.CCR-07-0088

    21. [21]

      C. Zhao, S.Y. Han, P.P. Li, Curr. Drug Deliv. 14 (2017) 282–288.  doi: 10.3390/ma10030282

    22. [22]

      G. Zhu, Y. Shao, Y. Liu, et al., Trac-Trends Anal. Chem. 143 (2021) 116351.  doi: 10.1016/j.trac.2021.116351

    23. [23]

      L. Zhang, A. Vertes, Angew. Chem. Int. Ed. 57 (2018) 4466–4477.  doi: 10.1002/anie.201709719

    24. [24]

      Y. Liu, Y. Mi, T. Mueller, et al., Nat. Biotechnol. 37 (2019) 314–322.  doi: 10.1038/s41587-019-0037-y

    25. [25]

      U. Ben-David, B. Siranosian, G. Ha, et al., Nature 560 (2018) 325–330.  doi: 10.1038/s41586-018-0409-3

    26. [26]

      Y. Shen, B.U.S. Schmidt, H. Kubitschke, et al., Cancer Converg. 4 (2020) 1.  doi: 10.1186/s41236-020-0010-1

    27. [27]

      N. Pan, S.J. Standke, N.R. Kothapalli, et al., Anal. Chem. 91 (2019) 9018–9024.  doi: 10.1021/acs.analchem.9b01311

    28. [28]

      M. Sun, X. Chen, Z. Yang, Anal. Chim. Acta 1206 (2022) 339761.  doi: 10.1016/j.aca.2022.339761

    29. [29]

      Z. Shen, H. Zhao, H. Yao, et al., Chem. Sci. 13 (2022) 1641–1647.  doi: 10.1039/d1sc06366a

    30. [30]

      S. Xu, M. Liu, Y. Bai, et al., Angew. Chem. Int. Ed. 60 (2021) 1806–1812.  doi: 10.1002/anie.202009682

    31. [31]

      X. Chen, Z. Peng, Z. Yang, Chem. Sci. 13 (2022) 6687–6695.  doi: 10.1039/d2sc02298b

    32. [32]

      M. Zhuang, Z. Hou, P. Chen, et al., Chem. Sci. 11 (2020) 7308–7312.  doi: 10.1039/d0sc00259c

    33. [33]

      W. Zhang, N. Li, L. Lin, et al., Small 15 (2019) 1903402.

    34. [34]

      G. Zhu, W. Zhang, Y. Zhao, et al., Anal. Chem. 95 (2023) 4712–4720.  doi: 10.1021/acs.analchem.2c05351

    35. [35]

      C. Wang, W. Hu, L. Guan, et al., Chin. Chem. Lett. 33 (2022) 2883–2892.  doi: 10.1016/j.cclet.2021.10.006

    36. [36]

      Y. Shao, Y. Zhou, Y. Liu, et al., Chem. Sci. 13 (2022) 8065–8073.  doi: 10.1039/d2sc02569h

    37. [37]

      L. Wang, W. Peng, T. Wu, et al., Cell Death Discov. 4 (2018) 84.  doi: 10.1038/s41420-018-0086-x

    38. [38]

      X. Li, T.M. Kamenecka, M.D. Cameron, Chem. Res. Toxicol. 22 (2009) 1736–1742.  doi: 10.1021/tx900256y

  • 加载中
    1. [1]

      Zhi LiShuya PanYuan TianShaowei LiuWeifeng WeiJinlin WangTianfeng ChenLing Wang . Selenium nanoparticles enhance the chemotherapeutic efficacy of pemetrexed against non-small cell lung cancer. Chinese Chemical Letters, 2024, 35(12): 110018-. doi: 10.1016/j.cclet.2024.110018

    2. [2]

      Bohao LiuXue JiangRuizhi NingHeng ZhaoYanpeng ZhangJunnan ZhangTianqing LiuDanyao QuYinhui BaoZhanchen GuoXiaoyan ZengShan GaoKun FanRunyi TaoJian JiGuangjian ZhangWeiwei Wu . Tedlar bag free: Accurate volatolomics of ⅠA stage non-small cell lung cancer come out in wash. Chinese Chemical Letters, 2025, 36(6): 110301-. doi: 10.1016/j.cclet.2024.110301

    3. [3]

      Haiyan LuJiayue YeYiping WeiHua ZhangKonstantin ChinginVladimir FrankevichHuanwen Chen . Tracing molecular margins of lung cancer by internal extractive electrospray ionization mass spectrometry. Chinese Chemical Letters, 2025, 36(2): 110077-. doi: 10.1016/j.cclet.2024.110077

    4. [4]

      Shaoqing DuXinyong LiuXueping HuPeng Zhan . Targeting novel sites represents an effective strategy for combating drug resistance. Chinese Chemical Letters, 2025, 36(1): 110378-. doi: 10.1016/j.cclet.2024.110378

    5. [5]

      Jing ChenPeisi XiePengfei WuYu HeZian LinZongwei Cai . MALDI coupled with laser-postionization and trapped ion mobility spectrometry contribute to the enhanced detection of lipids in cancer cell spheroids. Chinese Chemical Letters, 2024, 35(4): 108895-. doi: 10.1016/j.cclet.2023.108895

    6. [6]

      Wen SuSiying LiuQingfu ZhangZhongyan ZhouNa WangLei Yue . Temperature-controlled electrospray ionization tandem mass spectrometry study on protein/small molecule interaction. Chinese Chemical Letters, 2025, 36(5): 110237-. doi: 10.1016/j.cclet.2024.110237

    7. [7]

      Liping ZhaoXixi GuoZhimeng ZhangXi LuQingxuan ZengTianyun FanXintong ZhangFenbei ChenMengyi XuMin YuanZhenjun LiJiandong JiangJing PangXuefu YouYanxiang WangDanqing Song . Novel berberine derivatives as adjuvants in the battle against Acinetobacter baumannii: A promising strategy for combating multi-drug resistance. Chinese Chemical Letters, 2024, 35(10): 109506-. doi: 10.1016/j.cclet.2024.109506

    8. [8]

      Jiechen LiuXiaoguang LiRuiyang XiaYuqi WangFenghe ZhangYongzhi PangQing Li . Efficient suppression of oral squamous cell carcinoma through spatial dimension conversion drug delivery systems-enabled immunomodulatory-photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109619-. doi: 10.1016/j.cclet.2024.109619

    9. [9]

      Yanhua ChenXian DingJun ZhouZhaoying WangYunhai BoYing HuQingce ZangJing XuRuiping ZhangJiuming HeFen YangZeper Abliz . Plasma metabolomics combined with mass spectrometry imaging reveals crosstalk between tumor and plasma in gastric cancer genesis and metastasis. Chinese Chemical Letters, 2025, 36(1): 110351-. doi: 10.1016/j.cclet.2024.110351

    10. [10]

      Keqiang ShiXiujuan HongDongyan XuTao PanHuiwen WangHongru FengCheng GuoYuanjiang Pan . Analysis of RNA modifications in peripheral white blood cells from breast cancer patients by mass spectrometry. Chinese Chemical Letters, 2025, 36(3): 110079-. doi: 10.1016/j.cclet.2024.110079

    11. [11]

      Xiaofang LuoYe WuXiaokun ZhangMin TangFeiye JuZuodong QinGregory J DunsWei-Dong ZhangJiang-Jiang QinXin Luan . Peptide-based strategies for overcoming multidrug-resistance in cancer therapy. Chinese Chemical Letters, 2025, 36(1): 109724-. doi: 10.1016/j.cclet.2024.109724

    12. [12]

      Yang LiuYan LiuKaiyin YangZhiruo ZhangWenbo ZhangBingyou YangHua LiLixia Chen . A selective HK2 degrader suppresses SW480 cancer cell growth by degrading HK2. Chinese Chemical Letters, 2024, 35(8): 109264-. doi: 10.1016/j.cclet.2023.109264

    13. [13]

      Boran ChengLei CaoChen LiFang-Yi HuoQian-Fang MengGanglin TongXuan WuLin-Lin BuLang RaoShubin Wang . Fluorine-doped carbon quantum dots with deep-red emission for hypochlorite determination and cancer cell imaging. Chinese Chemical Letters, 2024, 35(6): 108969-. doi: 10.1016/j.cclet.2023.108969

    14. [14]

      Yuanzheng WangChen ZhangShuyan HanXiaoli KongChangyun QuanJun WuWei Zhang . Cancer cell membrane camouflaged biomimetic gelatin-based nanogel for tumor inhibition. Chinese Chemical Letters, 2024, 35(11): 109578-. doi: 10.1016/j.cclet.2024.109578

    15. [15]

      Yanfei LiuYaqin HuYifu TanQiwen ChenZhenbao Liu . Tumor acidic microenvironment activatable DNA nanostructure for precise cancer cell targeting and inhibition. Chinese Chemical Letters, 2025, 36(1): 110289-. doi: 10.1016/j.cclet.2024.110289

    16. [16]

      Yanjun CaiYong JiangYu ChenErzhuo ChengYuan GuYuwei LiQianqian LiuJian ZhangJifang LiuShisong HanBin Yang . Amplifying STING activation and immunogenic cell death by metal-polyphenol coordinated nanomedicines for enhanced cancer immunotherapy. Chinese Chemical Letters, 2025, 36(5): 110437-. doi: 10.1016/j.cclet.2024.110437

    17. [17]

      Jianqiu LiYi ZhangSongen LiuJie NiuRong ZhangYong ChenYu Liu . Cucurbit[8]uril-based non-covalent heterodimer realized NIR cell imaging through topological transformation from nanowire to nanorod. Chinese Chemical Letters, 2024, 35(10): 109645-. doi: 10.1016/j.cclet.2024.109645

    18. [18]

      Lixian FuYiyun TanYue DingWeixia QingYong Wang . Water–soluble and polarity–sensitive near–infrared fluorescent probe for long–time specific cancer cell membranes imaging and C. Elegans label. Chinese Chemical Letters, 2024, 35(4): 108886-. doi: 10.1016/j.cclet.2023.108886

    19. [19]

      Yihan ZhouDuo GaoYaying WangLi LiangQingyu ZhangWenwen HanJie WangChunliu ZhuXinxin ZhangYong Gan . Worm-like micelles facilitate the intestinal mucus diffusion and drug accumulation for enhancing colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108967-. doi: 10.1016/j.cclet.2023.108967

    20. [20]

      Tong TongLezong ChenSiying WuZhong CaoYuanbin SongJun Wu . Establishment of a leucine-based poly(ester amide)s library with self-anticancer effect as nano-drug carrier for colorectal cancer treatment. Chinese Chemical Letters, 2024, 35(12): 109689-. doi: 10.1016/j.cclet.2024.109689

Metrics
  • PDF Downloads(2)
  • Abstract views(666)
  • HTML views(22)

通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Address:Zhongguancun North First Street 2,100190 Beijing, PR China Tel: +86-010-82449177-888
Powered By info@rhhz.net

/

DownLoad:  Full-Size Img  PowerPoint
Return